Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression
Justin A. Spanier, Faye E. Nashold, Corwin D. Nelson, Corinne E. Praska, Colleen E. Hayes
Dive into the research topics of 'Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression'. Together they form a unique fingerprint.